- Home
- ONTF vs RZLT Comparison
ONTF vs RZLT Comparison
Compare ONTF & RZLT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ONTF
- RZLT
- Stock Information
- Founded
- ONTF 1998
- RZLT 2010
- Country
- ONTF United States
- RZLT United States
- Employees
- ONTF N/A
- RZLT N/A
- Industry
- ONTF Computer Software: Prepackaged Software
- RZLT Biotechnology: Pharmaceutical Preparations
- Sector
- ONTF Technology
- RZLT Health Care
- Exchange
- ONTF Nasdaq
- RZLT Nasdaq
- Market Cap
- ONTF 273.3M
- RZLT 283.3M
- IPO Year
- ONTF 2021
- RZLT N/A
- Fundamental
- Price
- ONTF $6.92
- RZLT $5.44
- Analyst Decision
- ONTF Hold
- RZLT Strong Buy
- Analyst Count
- ONTF 3
- RZLT 8
- Target Price
- ONTF $8.00
- RZLT $11.63
- AVG Volume (30 Days)
- ONTF 95.9K
- RZLT 601.9K
- Earning Date
- ONTF 02-25-2025
- RZLT 02-11-2025
- Dividend Yield
- ONTF N/A
- RZLT N/A
- EPS Growth
- ONTF N/A
- RZLT N/A
- EPS
- ONTF N/A
- RZLT N/A
- Revenue
- ONTF $150,738,000.00
- RZLT N/A
- Revenue This Year
- ONTF N/A
- RZLT N/A
- Revenue Next Year
- ONTF N/A
- RZLT N/A
- P/E Ratio
- ONTF N/A
- RZLT N/A
- Revenue Growth
- ONTF N/A
- RZLT N/A
- 52 Week Low
- ONTF $5.37
- RZLT $0.93
- 52 Week High
- ONTF $8.35
- RZLT $6.19
- Technical
- Relative Strength Index (RSI)
- ONTF 64.23
- RZLT 61.40
- Support Level
- ONTF $6.73
- RZLT $4.77
- Resistance Level
- ONTF $6.98
- RZLT $5.54
- Average True Range (ATR)
- ONTF 0.15
- RZLT 0.34
- MACD
- ONTF 0.04
- RZLT 0.07
- Stochastic Oscillator
- ONTF 83.59
- RZLT 90.47
About ONTF ON24 Inc.
ON24 Inc provides a cloud-based digital experience platform that enables businesses to convert customer engagement into revenue through interactive webinar experiences, virtual event experiences, and multimedia content experiences. The company derives revenue from subscription agreements with customers for accessing the platform and related services. Geographically, it derives a majority of revenue from the United States.
About RZLT Rezolute Inc. (NV)
Rezolute Inc is a biopharmaceutical company. The company develops novel, sustained-release injectable therapies. It applies proprietary formulation and manufacturing capabilities to known, well-characterized molecules to create differentiated, patent-protected therapies that have the potential to significantly improve existing standards of care. Its pipeline products include RZ358 and RZ402.